BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38199930)

  • 1. Incidence of type 2 diabetes after gastric by-pass surgery in a Swedish controlled cohort study.
    Jamaly S; Lundberg CE; Adiels M; Lagergren J; Björck L; Rosengren A
    Obes Res Clin Pract; 2024; 18(1):15-20. PubMed ID: 38199930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of obesity and excess risk of developing heart failure in a controlled cohort study.
    Lundberg CE; Jamaly S; Adiels M; Lagergren J; Svensson CJ; Björck L; Rosengren A
    ESC Heart Fail; 2022 Jun; 9(3):1844-1852. PubMed ID: 35274493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Gastric Bypass Surgery With Risk of Developing Diabetic Retinopathy Among Patients With Obesity and Type 2 Diabetes in Sweden: An Observational Study.
    Åkerblom H; Franzén S; Zhou C; Morén Å; Ottosson J; Sundbom M; Eliasson B; Svensson AM; Granstam E
    JAMA Ophthalmol; 2021 Feb; 139(2):200-205. PubMed ID: 33443540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study.
    Johansson K; Svensson PA; Söderling J; Peltonen M; Neovius M; Carlsson LMS; Sjöholm K
    Lancet Diabetes Endocrinol; 2021 Aug; 9(8):515-524. PubMed ID: 34217404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study.
    Höskuldsdóttir G; Ekelund J; Miftaraj M; Wallenius V; Ottosson J; Näslund I; Gudbjörnsdottir S; Sattar N; Svensson AM; Eliasson B
    Diabetes Care; 2020 Dec; 43(12):3079-3085. PubMed ID: 33023988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric Bypass Surgery Reduces De Novo Cases of Type 2 Diabetes to Population Levels: A Nationwide Cohort Study From Sweden.
    Backman O; Bruze G; Näslund I; Ottosson J; Marsk R; Neovius M; Näslund E
    Ann Surg; 2019 May; 269(5):895-902. PubMed ID: 30102631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture risk after three bariatric surgery procedures in Swedish obese subjects: up to 26 years follow-up of a controlled intervention study.
    Ahlin S; Peltonen M; Sjöholm K; Anveden Å; Jacobson P; Andersson-Assarsson JC; Taube M; Larsson I; Lohmander LS; Näslund I; Svensson PA; Carlsson LMS
    J Intern Med; 2020 May; 287(5):546-557. PubMed ID: 32128923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms.
    Holmberg D; Santoni G; Xie S; Lagergren J
    Aliment Pharmacol Ther; 2019 Jul; 50(2):159-166. PubMed ID: 31165515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study.
    Eliasson B; Liakopoulos V; Franzén S; Näslund I; Svensson AM; Ottosson J; Gudbjörnsdottir S
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):847-54. PubMed ID: 26429401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits.
    Liakopoulos V; Franzén S; Svensson AM; Sattar N; Miftaraj M; Björck S; Ottosson J; Näslund I; Gudbjörnsdottir S; Eliasson B
    Diabetes Care; 2020 Jun; 43(6):1276-1284. PubMed ID: 32152136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study.
    Madsen LR; Baggesen LM; Richelsen B; Thomsen RW
    Diabetologia; 2019 Apr; 62(4):611-620. PubMed ID: 30734055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.
    Carlsson LMS; Sjöholm K; Karlsson C; Jacobson P; Andersson-Assarsson JC; Svensson PA; Larsson I; Hjorth S; Neovius M; Taube M; Carlsson B; Peltonen M
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):271-279. PubMed ID: 28237791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies.
    Neovius M; Bruze G; Jacobson P; Sjöholm K; Johansson K; Granath F; Sundström J; Näslund I; Marcus C; Ottosson J; Peltonen M; Carlsson LMS
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):197-207. PubMed ID: 29329975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study.
    Höskuldsdóttir G; Sattar N; Miftaraj M; Näslund I; Ottosson J; Franzén S; Svensson AM; Eliasson B
    J Am Heart Assoc; 2021 Apr; 10(7):e019323. PubMed ID: 33754795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.
    Sjöström L; Peltonen M; Jacobson P; Ahlin S; Andersson-Assarsson J; Anveden Å; Bouchard C; Carlsson B; Karason K; Lönroth H; Näslund I; Sjöström E; Taube M; Wedel H; Svensson PA; Sjöholm K; Carlsson LM
    JAMA; 2014 Jun; 311(22):2297-304. PubMed ID: 24915261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden.
    Marsk R; Jonas E; Rasmussen F; Näslund E
    Diabetologia; 2010 Nov; 53(11):2307-11. PubMed ID: 20495972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study.
    Booth H; Khan O; Prevost T; Reddy M; Dregan A; Charlton J; Ashworth M; Rudisill C; Littlejohns P; Gulliford MC
    Lancet Diabetes Endocrinol; 2014 Dec; 2(12):963-8. PubMed ID: 25466723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy in people with Type 2 diabetes and obesity treated by Roux-en-Y gastric bypass compared with non-operated controls: with focus on the role of diabetes remission in a cross-sectional and a 6-year follow-up study.
    Madsen LR; Bek T; Richelsen B
    Diabet Med; 2019 Apr; 36(4):457-464. PubMed ID: 30537170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.
    Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pros and cons of gastric bypass surgery in individuals with obesity and type 2 diabetes: nationwide, matched, observational cohort study.
    Liakopoulos V; Franzén S; Svensson AM; Miftaraj M; Ottosson J; Näslund I; Gudbjörnsdottir S; Eliasson B
    BMJ Open; 2019 Jan; 9(1):e023882. PubMed ID: 30782717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.